Impact of Treatment with Renin–Angiotensin System Inhibitors on Clinical Outcomes in Hypertensive Patients Hospitalized with COVID-19

INTRODUCTION: Concerns have been raised about the possible harmfulness of angiotensin-converter enzyme inhibitors (ACEi) and aldosterone receptor blockers (ARB) in patients with COVID-19. However, few data from a European population have been published, especially from hypertensive patients. AIM: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Negreira-Caamaño, Martin, Piqueras-Flores, Jesus, Martínez-DelRio, Jorge, Nieto-Sandoval-Martin-DeLaSierra, Patricia, Aguila-Gordo, Daniel, Mateo-Gomez, Cristina, Salas-Bravo, Daniel, Rodriguez-Martinez, Marta, Negreira-Caamaño, Martín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501502/
https://www.ncbi.nlm.nih.gov/pubmed/32949380
http://dx.doi.org/10.1007/s40292-020-00409-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501502/
https://www.ncbi.nlm.nih.gov/pubmed/32949380
http://dx.doi.org/10.1007/s40292-020-00409-7

Ejemplares similares